Top 10 Companies in the Marine Omega‑3 Fatty Acids Market (2026): Market Leaders Driving Global Health

MARKET INSIGHTS

Global marine omega‑3 fatty acids market size was valued at USD 2.65 billion in 2024. The market is projected to grow from USD 2.78 billion in 2025 to USD 3.79 billion by 2032, exhibiting a CAGR of 4.6 % during the forecast period.

Marine omega‑3 fatty acids are essential polyunsaturated fats primarily derived from fish oil and algae. These nutrients, including EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), play critical roles in cardiovascular health, brain function, and inflammatory response regulation. While plant‑based ALA (alpha‑linolenic acid) exists, marine sources provide the more bioavailable EPA and DHA forms that the human body can readily utilize.

The market growth is fueled by increasing consumer awareness about preventive healthcare and rising demand for dietary supplements. However, sustainability concerns regarding fish stocks present challenges that are driving innovation in alternative sources like algae‑based production. Major players are expanding their production capabilities to meet the growing demand, with North America currently dominating the market due to high supplement consumption and developed healthcare infrastructure.

Marine Omega‑3 Fatty Acids Market – View in Detailed Research Report

🔟 10. Bioprocess Algae (USA)

Headquarters: San Francisco, California, USA
Key Offering: Algal EPA/DHA concentrates, plant‑based omega‑3 blends

Bioprocess Algae leverages proprietary photobioreactor technology to produce high‑purity EPA and DHA from marine microalgae, positioning itself as a leading supplier of vegan‑friendly omega‑3s. The company’s focus on closed‑loop cultivation reduces water usage and eliminates marine‑pollutant risks, appealing to health‑conscious and sustainability‑driven consumers.

Sustainability & Growth Initiatives:

• Closed‑loop photobioreactor system with 90 % water recirculation
• Carbon‑neutral production footprint through renewable energy integration
• Partnerships with nutraceutical firms to develop high‑concentration blends for infant formula and sports nutrition

9️⃣ 9. GC Rieber Oils (Norway)

Headquarters: Oslo, Norway
Key Offering: Premium fish oil extracts, traceable sourcing, specialty omega‑3 blends

GC Rieber Oils is renowned for its rigorous traceability and sustainable fishing certifications. The firm’s extensive supply chain network spans the North Atlantic, enabling consistent supply of high‑purity EPA/DHA for both dietary supplements and pharmaceutical applications.

Sustainability & Growth Initiatives:

• ISO 14001 certified processing facilities
• Active engagement in marine conservation programs to safeguard fish stocks
• Expansion of high‑concentration product lines to capture the premium prescription market

8️⃣ 8. KD Pharma Group (Germany)

Headquarters: Berlin, Germany
Key Offering: Pharmaceutical‑grade omega‑3 formulations, prescription supplements

KD Pharma Group specializes in concentrated omega‑3s for clinical use, including hypertriglyceridemia and neuro‑inflammation indications. The company’s R&D pipeline focuses on optimizing bioavailability through advanced encapsulation technologies.

Sustainability & Growth Initiatives:

• Investment in high‑efficiency extraction to lower energy consumption
• Collaborations with academic institutions on nutrigenomic personalization of omega‑3 dosing
• Targeted expansion into emerging markets with rising cardiovascular disease prevalence

7️⃣ 7. PolaRIS (France)

Headquarters: Lyon, France
Key Offering: High‑purity fish oil concentrates, specialty blends for infant nutrition

Polaris has built a reputation for delivering ultra‑pure omega‑3s with strict contaminant limits. The firm’s partnership model with infant formula manufacturers has positioned it as a preferred supplier for DHA‑enriched products.

Sustainability & Growth Initiatives:

• Zero‑waste processing streams
• Certification under the Marine Stewardship Council (MSC)
• Development of algae‑derived supplements to diversify sourcing

6️⃣ 6. Omega Protein (USA)

Headquarters: Houston, Texas, USA
Key Offering: Omega‑3 protein blends, functional food ingredients

Omega Protein’s portfolio extends beyond pure oils to include protein‑omega‑3 blends that enhance the nutritional profile of fortified foods and beverages. The company’s focus on functional food applications aligns with the growing consumer demand for integrated health solutions.

Sustainability & Growth Initiatives:

• Partnerships with regenerative aquaculture farms
• Investments in encapsulation technologies to reduce off‑flavors
• Strategic expansion into the pet food sector with joint‑action blends

5️⃣ 5. Croda (UK)

Headquarters: Holton, United Kingdom
Key Offering: Specialty omega‑3 concentrates, feed additives

Croda’s expertise in specialty chemicals positions it to supply high‑concentration omega‑3s for both human and animal nutrition. The firm’s strong R&D capabilities allow rapid development of novel delivery systems for improved stability.

Sustainability & Growth Initiatives:

• Carbon‑neutral manufacturing processes
• Participation in the Sustainable Fish Initiative
• Expansion of plant‑based omega‑3 formulations to capture the vegan market

4️⃣ 4. Golden Omega (Chile)

Headquarters: Santiago, Chile
Key Offering: Premium fish oil extracts, high‑purity EPA/DHA blends

Golden Omega’s operations in the Pacific region give it access to abundant fish stocks. The company’s focus on quality control and traceability has earned it certifications that appeal to global nutraceutical manufacturers.

Sustainability & Growth Initiatives:

• MSC‑certified sourcing across all product lines
• Investment in renewable energy for processing facilities
• Development of algae‑derived omega‑3s to complement fish‑oil offerings

3️⃣ 3. Pelagia (EPAX) (Norway)

Headquarters: Oslo, Norway
Key Offering: High‑purity fish oils, specialty blends for supplements and pharmaceuticals

Pelagia’s long‑standing heritage in fish‑oil production is matched by its commitment to advanced purification. The company’s collaborations with health‑care providers enable it to supply prescription‑grade omega‑3s for cardiovascular and neuro‑cognitive indications.

Sustainability & Growth Initiatives:

• ISO 9001 and ISO 14001 certifications
• Active participation in the Aquaculture Stewardship Alliance
• Expansion into algae‑based production to diversify supply

2️⃣ 2. BASF (Germany)

Headquarters: Ludwigshafen, Germany
Key Offering: Concentrated omega‑3 formulations, process technologies

BASF’s global footprint and robust R&D pipeline support the development of high‑purity omega‑3s for dietary supplements, fortified foods, and pharmaceutical applications. The firm’s focus on process efficiency has reduced production costs and improved product consistency.

Sustainability & Growth Initiatives:

• Investment in biorefinery technologies to minimize waste
• Partnerships with marine conservation NGOs
• Strategic acquisitions to strengthen algae‑based omega‑3 capabilities

1️⃣ 1. DSM (Netherlands)

Headquarters: Heerlen, Netherlands
Key Offering: High‑purity fish‑oil concentrates, functional ingredient solutions

DSM’s integrated supply chain, from sourcing to processing, enables the company to deliver consistently high‑quality omega‑3s. Its global presence and commitment to sustainability make it a preferred partner for nutraceutical and pharmaceutical manufacturers seeking reliable, traceable ingredients.

Sustainability & Growth Initiatives:

• Carbon‑neutral production across all facilities
• MSC certification for all fish‑oil streams
• Investment in algae‑based production to secure future supply chains

Download FREE Sample Report: Marine Omega‑3 Fatty Acids Market – View in Detailed Research Report

Get Full Report: Marine Omega‑3 Fatty Acids Market – View in Detailed Research Report

Outlook

The marine omega‑3 sector is expected to maintain a steady trajectory as consumer demand for heart‑health and cognitive‑support products rises. The increasing prevalence of cardiovascular disease, coupled with a growing emphasis on preventive care, will keep the supplement and pharmaceutical segments on an upward swing. Meanwhile, regulatory alignment around health claims and stringent contaminant limits will shape product development, pushing companies toward higher‑purity, traceable sources.

Future Trends

• Algae‑derived omega‑3s are poised to capture a larger share of the market, driven by sustainability concerns and consumer preference for plant‑based ingredients.
• Personalized nutrition platforms, integrating nutrigenomic data, will enable precise omega‑3 dosing for individual risk profiles.
• High‑concentration formulations tailored for prescription use will expand the pharmaceutical footprint, offering premium pricing opportunities.
• Advances in encapsulation and micro‑encapsulation technologies will reduce oxidation risk, improving shelf life and expanding application potential in fortified foods.